I am a
Home I AM A Search Login

Papers of the Week


Papers: 12 Jan 2019 - 18 Jan 2019


Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 Jan 16


J Headache Pain


20


1

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention.

Authors

Sacco S, Bendtsen L, Ashina M, Reuter U, Terwindt G, Mitsikostas D-D, Martelletti P
J Headache Pain. 2019 Jan 16; 20(1):6.
PMID: 30651064.

Abstract

Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-related peptide (eptinezumab, fremanezumab, and galcanezumab). The aim of this document by the European Headache Federation (EHF) is to provide an evidence-based and expert-based guideline on the use of the monoclonal antibodies acting on the calcitonin gene-related peptide for migraine prevention.